Search
for
Sort by
Research 661–690 of 1000+
- The role of fractional laser‐assisted drug delivery in enhancing the efficacy of topical bimatoprost solution in the treatment of alopecia areata: An intra‐patient comparative randomized clinical trial
- Upadacitinib for the treatment of alopecia areata – A case report
- Quoi de neuf en dermatologie pédiatrique ?
- Polietilen glikol kaplı manyetik nanoparçaıkların sentezi ve karakterizasyonu ve anti-kanser ilaç taşınmasında kullanımı.
- JAK inhibitors for alopecia areata: a systematic review and meta‐analysis
- Topical Ruxolitinib for the Treatment of Alopecia Universalis
- Health-related quality of life (HRQoL) among patients with alopecia areata (AA): A systematic review
- Hair-Growth Potential of Ginseng and Its Major Metabolites: A Review on Its Molecular Mechanisms
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Five‐year experience in the treatment of alopecia areata with DPC
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Alopecia Areata: An Autoimmune Disease of Multiple Players
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Multiple Autoimmune Syndrome type 3- Thyroiditis, Vitiligo and Alopecia Areata
- Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update
- Dupilumab therapy for alopecia areata in pediatric patients with concomitant atopic dermatitis
- Dupilumab treatment for atopic dermatitis leading to unexpected treatment for alopecia universalis
- Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review
- Under Development JAK Inhibitors for Dermatologic Diseases
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib
- Alopecia areata following COVID-19 vaccine: a systematic review
- Complete Blood Collection-based Systemic Inflammation Biomarkers as a Severity Biomarker in Alopecia Areata: A Cross-sectional Study
- Janus kinase inhibitors for alopecia areata
- Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Single-cell analysis of temporal immune cell dynamics in alopecia areata reveals a causal role for clonally expanded CD8+ T cells in disease
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- Broussonetia papyrifera Promotes Hair Growth Through the Regulation of β-Catenin and STAT6 Target Proteins: A Phototrichogram Analysis of Clinical Samples